What's new

Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 6, Status: Authorised

Feb 13, 2025 - 10:51
 0
Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Xaluprine (previously ...

Next Article

Iro appoints first-ever creative director Nicolas Rohaut

Related Posts

Human medicines European public assessment report (EPAR): Somavert, pegvisomant, Date of authorisation: 12/11/2002, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Template for a European Union herbal monograph

Template for a European Union herbal monograph

Feb 17, 2025  0